Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma

References

• Razumilava N, Gores GJ. (2014). Cholangiocarcinoma. Lancet 383:2168–79.
   PubMed Web of Science ®Google Scholar
• Shaib Y, El-Serag HB. (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115–25.
   PubMed Web of Science ®Google Scholar
• Khan SA, Toledano MB, Taylor-Robinson SD. (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10:77–82.
   PubMed Web of Science ®Google Scholar
• Shaib YH, Davila JA, McGlynn K, El-Serag HB. (2004). Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?. J Hepatol 40:472–7.
   PubMed Web of Science ®Google Scholar
• Anderson CD, Pinson CW, Berlin J, Chari RS. (2004). Diagnosis and treatment of cholangiocarcinoma. Oncologist 9:43–57.
   PubMed Web of Science ®Google Scholar
• Puhalla H, Schuell B, Pokorny H, et al. (2005). Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg 189:173–7.
   PubMed Web of Science ®Google Scholar
• Tan JC, Coburn NG, Baxter NN, et al. (2008). Surgical management of intrahepatic cholangiocarcinoma – a population-based study. Ann Surg Oncol 15:600–8.
   PubMed Web of Science ®Google Scholar
• Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. (2014). Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–74.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Ariizumi S. (2011). Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today 41:896–902.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim JH, Yoon HJ, et al. (2011). Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol 66:322–8.
   PubMed Web of Science ®Google Scholar
• Saxena A, Bester L, Chua TC, et al. (2010). Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol 17:484–91.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Lagana D, Cotta E, et al. (2010). Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol 33:835–9.
   PubMed Web of Science ®Google Scholar
• Kim JH, Won HJ, Shin YM, et al. (2011). Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 196:W205–9.
   PubMed Web of Science ®Google Scholar
• Bale R, Schullian P, Haidu M, Widmann G. (2013). Stereotactic radiofrequency ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection. Wien Med Wochenschr 163:128–31.
   PubMedGoogle Scholar
• Zhang SJ, Hu P, Wang N, et al. (2013). Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol 20:3596–602.
   PubMed Web of Science ®Google Scholar
• Xu HX, Wang Y, Lu MD, Liu LN. (2012). Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol 85:1078–84.
   PubMed Web of Science ®Google Scholar
• Wright AS, Sampson LA, Warner TF, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236:132–9.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu X, et al. (2011). A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 79:124–30.
   PubMed Web of Science ®Google Scholar
• Brace CL. (2009). Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 38:135–43.
   PubMedGoogle Scholar
• Zhang K, Yu J, Zhou F, et al. (2016). Impact of timing and cycles of systemic chemotherapy on survival outcome of colorectal liver metastases patients treated by percutaneous microwave ablation. Int J Hyperthermia 32:531–8.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. (2014). Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273:241–60.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD (2005). Management of hepatocellular carcinoma. Hepatology 42:1208–36.
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Galle PR, Khan SA, et al. (2014). Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–89.
   PubMed Web of Science ®Google Scholar
• Endo I, Gonen M, Yopp AC, et al. (2008). Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248:84–96.
   PubMed Web of Science ®Google Scholar
• Lang H, Sotiropoulos GC, Sgourakis G, et al. (2009). Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–28.
   PubMed Web of Science ®Google Scholar
• Jonas S, Thelen A, Benckert C, et al. (2009). Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–9.
   PubMed Web of Science ®Google Scholar
• Choi SB, Kim KS, Choi JY, et al. (2009). The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–56.
   PubMed Web of Science ®Google Scholar
• Ellis MC, Cassera MA, Vetto JT, et al. (2011). Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors. HPB (Oxford) 13:59–63.
   PubMed Web of Science ®Google Scholar
• Wu ZF, Wu XY, Zhu N, et al. (2015). Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 21:935–43.
   PubMed Web of Science ®Google Scholar
• Jutric Z, Johnston WC, Hoen HM, et al. (2016). Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database. HPB (Oxford) 18:79–87.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Yakoob MY, Kim Y, et al. (2015). The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 22:4020–8.
   PubMed Web of Science ®Google Scholar
• Park J, Kim MH, Kim KP, et al. (2009). Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 3:298–305.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim BK, Kim SU, et al. (2014). Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study. J Gastroenterol Hepatol 29:1463–9.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Nishijima N, Enomoto H, et al. (2017). Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis. J Cancer 8:378–87.
   PubMed Web of Science ®Google Scholar
• Racanelli V, Rehermann B. (2006). The liver as an immunological organ. Hepatology 43:S54–S62.
   PubMed Web of Science ®Google Scholar
• Jenne CN, Kubes P. (2013). Immune surveillance by the liver. Nat Immunol 14:996–1006.
   PubMed Web of Science ®Google Scholar
• Fu Y, Yang W, Wu W, et al. (2012). Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol 23:642–9.
   PubMed Web of Science ®Google Scholar